Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

TheraSphere(R) YTTRIUM-90 CLASS MICROSPHERE INJECTION TheraSphere¿ is indicated for radiation Recalled by Biocompatibles U.K., Ltd. Due to Mislabeling

Date: September 21, 2015
Company: Biocompatibles U.K., Ltd.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Biocompatibles U.K., Ltd. directly.

Affected Products

TheraSphere(R) YTTRIUM-90 CLASS MICROSPHERE INJECTION TheraSphere¿ is indicated for radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable HCC who can have placement of appropriately positioned hepatic arterial catheters.

Quantity: 64 doses

Why Was This Recalled?

One mislabeled dose of TheraSphere¿ Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.

Where Was This Sold?

This product was distributed to 17 states: CA, FL, IL, IN, KY, MD, MA, MI, MN, NV, NY, OH, OR, PA, TX, WA, WI

Affected (17 states)Not affected

About Biocompatibles U.K., Ltd.

Biocompatibles U.K., Ltd. has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report